Cynata Therapeutics Limited (ASX:CYP)
Australia
· Delayed Price · Currency is AUD
0.325
-0.015 (-4.41%)
Mar 9, 2026, 3:57 PM AEST
Cynata Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -8.4 | -9.39 | -9.74 | -14.28 | -5.45 | -7.69 | |
| Depreciation & Amortization | - | - | - | - | 0.28 | 0.28 | |
| Other Amortization | 0.28 | 0.28 | 0.28 | 0.28 | - | - | |
| Stock-Based Compensation | 0.26 | 0.26 | 0.23 | 0.33 | 1.03 | 1.54 | |
| Other Operating Activities | -0.44 | 0 | 0 | 0.07 | -0.17 | -0.05 | |
| Change in Accounts Receivable | 0.03 | 0.03 | 0.36 | -0.36 | 0.02 | -0.16 | |
| Change in Accounts Payable | 0.04 | 0.04 | -1.12 | -0.26 | 0.95 | 0.74 | |
| Change in Other Net Operating Assets | 0.05 | 0.05 | 0.03 | -0.07 | 0.03 | 0.17 | |
| Operating Cash Flow | -8.18 | -8.72 | -9.96 | -14.28 | -3.3 | -5.16 | |
| Sale (Purchase) of Intangibles | -0.05 | -0.05 | - | - | - | - | |
| Investing Cash Flow | - | -0.05 | - | - | - | - | |
| Issuance of Common Stock | 0.14 | 8.14 | - | 7.04 | - | 18.31 | |
| Other Financing Activities | -0.02 | -0.52 | - | -0.32 | 0.21 | -0.11 | |
| Financing Cash Flow | 0.11 | 7.61 | - | 6.72 | 0.21 | 18.2 | |
| Foreign Exchange Rate Adjustments | 0.15 | -0 | -0 | -0.07 | 0.17 | 0.03 | |
| Net Cash Flow | -7.92 | -1.16 | -9.96 | -7.63 | -2.92 | 13.07 | |
| Cash Income Tax Paid | - | -1.89 | -2.32 | -1.65 | -0.83 | -1.39 | |
| Levered Free Cash Flow | -5.02 | -5.44 | -6.61 | -9.38 | -1.27 | -2.34 | |
| Unlevered Free Cash Flow | -5.02 | -5.44 | -6.61 | -9.38 | -1.27 | -2.34 | |
| Change in Working Capital | 0.13 | 0.13 | -0.73 | -0.68 | 1.01 | 0.76 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.